Saha, Anjan K. https://orcid.org/0000-0001-6721-1599
Mourad, Mohamad
Kaplan, Mark H.
Chefetz, Ilana
Malek, Sami N.
Buckanovich, Ronald
Markovitz, David M.
Contreras-Galindo, Rafael
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (F30-CA-210379, 5T32GM007863-34)
Scleroderma Foundation
Article History
Received: 8 March 2019
Accepted: 23 July 2019
First Online: 2 August 2019
Competing Interests
: Anjan K. Saha is an equity holder in Deoxylytics, LLC. All other authors declare no competing interests.